Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
12Customers
1Debt Items
20Related Chains
Source-Backed Evidence Depth
Adlai Nortye Ltd. (ANL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
16Total relationships
1Distinct source URLs
4High confidence
0.753Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Adlai Nortye Ltd. Suppliers
Ticker
Name
Confidence
Evidence
JIANGSU-AOSAIKANG-PHARMACEUTICAL-CO-LTD
JIANGSU-AOSAIKANG-PHARMACEUTICAL-CO-LTD
90%
Under certain circumstances, the royalties and milestone payments payable to us under these agreements (such as our exclusive license agreement with Jiangsu Aosaikang Pharmaceutical Co., Ltd for AN90…
XIAMEN-BIOTIME-BIOTECHNOLOGY-CO-LTD
XIAMEN-BIOTIME-BIOTECHNOLOGY-CO-LTD
90%
Under certain circumstances, the royalties and milestone payments payable to us under these agreements (such as our exclusive license agreement with Jiangsu Aosaikang Pharmaceutical Co., Ltd for AN90…
Adlai Nortye Ltd. Customers
Ticker
Name
Confidence
Evidence
BMY
Bristol-Myers Squibb Company
72%
Reciprocal relationship from BMY graph: Reciprocal relationship from ANL graph: Reciprocal relationship from BMY graph: Reciprocal relationship from ANL graph: Reciprocal relationship from BMY graph:…
BMY
Bristol-Myers Squibb Company
72%
asing by US$5 million as a result of advanced payments from customer. Investing activities In 2025, our net cash used in investing activities was US$15.6 million, primarily as a result of purchases o…
BMYMP
Bristol-Myers Squibb Co
72%
asing by US$5 million as a result of advanced payments from customer. Investing activities In 2025, our net cash used in investing activities was US$15.6 million, primarily as a result of purchases o…
BMYMP
Bristol-Myers Squibb Co
72%
Reciprocal relationship from BMYMP graph: Reciprocal relationship from ANL graph: Reciprocal relationship from BMYMP graph: Reciprocal relationship from ANL graph: asing by US$5 million as a result o…
asing by US$5 million as a result of advanced payments from customer. Investing activities In 2025, our net cash used in investing activities was US$15.6 million, primarily as a result of purchases o…
Reciprocal relationship from KKR graph: Reciprocal relationship from ANL graph: Reciprocal relationship from KKR graph: Reciprocal relationship from ANL graph: Reciprocal relationship from KKR graph:…
asing by US$5 million as a result of advanced payments from customer. Investing activities In 2025, our net cash used in investing activities was US$15.6 million, primarily as a result of purchases o…
Reciprocal relationship from NVSEF graph: Reciprocal relationship from ANL graph: Reciprocal relationship from NVSEF graph: Reciprocal relationship from ANL graph: asing by US$5 million as a result o…
SNYNF
Sanofi
72%
asing by US$5 million as a result of advanced payments from customer. Investing activities In 2025, our net cash used in investing activities was US$15.6 million, primarily as a result of purchases o…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from ANL graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from ANL graph: asing by US$5 million as a result o…
Reciprocal relationship from CGEN graph: Reciprocal relationship from ANL graph: Reciprocal relationship from CGEN graph: Reciprocal relationship from ANL graph: Reciprocal relationship from CGEN gra…
HUMAN-RESOURCES
HUMAN-RESOURCES
62%
ry is cost containment. In recent years, government authorities and third-party payors, such as private health insurers and health maintenance organizations have attempted to control costs by limitin…
Adlai Nortye Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
ANL-DEBT
Debt stack $26.4M
90%
Market cache reports total debt of $26.4M.
Adlai Nortye Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Adlai Nortye Ltd..
Adlai Nortye Ltd. Ownership
Holder
Name
Confidence
Evidence
ANL-OWNER-VENROCK-ADVISER-LLC
Venrock Adviser, LLC
90%
13F overlay lists Venrock Adviser, LLC as top holder; 27 tracked holders.
